Catálogo de publicaciones - revistas

Compartir en
redes sociales


Science

Resumen/Descripción – provisto por la editorial

No disponible.

Palabras clave – provistas por la editorial

No disponibles.

Disponibilidad
Institución detectada Período Navegá Descargá Solicitá
No detectada desde mar. 1997 / hasta dic. 2023 Science Journals

Información

Tipo de recurso:

revistas

ISSN impreso

0036-8075

ISSN electrónico

1095-9203

Editor responsable

American Association for the Advancement of Science (AAAS)

País de edición

Estados Unidos

Fecha de publicación

Cobertura temática

Tabla de contenidos

Prediction of higher-selectivity catalysts by computer-driven workflow and machine learning

Andrew F. ZahrtORCID; Jeremy J. HenleORCID; Brennan T. RoseORCID; Yang WangORCID; William T. DarrowORCID; Scott E. DenmarkORCID

<jats:title>Predicting catalyst selectivity</jats:title> <jats:p> Asymmetric catalysis is widely used in chemical research and manufacturing to access just one of two possible mirror-image products. Nonetheless, the process of tuning catalyst structure to optimize selectivity is still largely empirical. Zahrt <jats:italic>et al.</jats:italic> present a framework for more efficient, predictive optimization. As a proof of principle, they focused on a known coupling reaction of imines and thiols catalyzed by chiral phosphoric acid compounds. By modeling multiple conformations of more than 800 prospective catalysts, and then training machine-learning algorithms on a subset of experimental results, they achieved highly accurate predictions of enantioselectivities. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" related-article-type="in-this-issue" xlink:href="10.1126/science.aau5631">eaau5631</jats:related-article> </jats:p>

Palabras clave: Multidisciplinary.

Pp. No disponible

The importance of synthetic chemistry in the pharmaceutical industry

Kevin R. CamposORCID; Paul J. ColemanORCID; Juan C. AlvarezORCID; Spencer D. DreherORCID; Robert M. GarbaccioORCID; Nicholas K. TerrettORCID; Richard D. TillyerORCID; Matthew D. TruppoORCID; Emma R. Parmee

<jats:title>Synthetic innovation in drug development</jats:title> <jats:p> Chemical synthesis plays a key role in pharmaceutical research and development. Campos <jats:italic>et al.</jats:italic> review some of the advantages that have come from recent innovations in synthetic methods. In particular, they highlight small-molecule catalysts stimulated by visible light, enzymes engineered for versatility beyond their intrinsic function, and bio-orthogonal reactions to selectively modify proteins for conjugation. High-throughput techniques are also poised to accelerate methods optimization from small-scale discovery to large-scale production, and complementary machine-learning approaches are just coming into focus. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" related-article-type="in-this-issue" xlink:href="10.1126/science.aat0805">eaat0805</jats:related-article> </jats:p>

Palabras clave: Multidisciplinary.

Pp. No disponible

Cortical column and whole-brain imaging with molecular contrast and nanoscale resolution

Ruixuan GaoORCID; Shoh M. AsanoORCID; Srigokul UpadhyayulaORCID; Igor PisarevORCID; Daniel E. MilkieORCID; Tsung-Li LiuORCID; Ved Singh; Austin Graves; Grace H. HuynhORCID; Yongxin ZhaoORCID; John BogovicORCID; Jennifer Colonell; Carolyn M. Ott; Christopher ZugatesORCID; Susan TappanORCID; Alfredo Rodriguez; Kishore R. Mosaliganti; Shu-Hsien SheuORCID; H. Amalia Pasolli; Song Pang; C. Shan XuORCID; Sean G. MegasonORCID; Harald HessORCID; Jennifer Lippincott-SchwartzORCID; Adam Hantman; Gerald M. RubinORCID; Tom Kirchhausen; Stephan SaalfeldORCID; Yoshinori Aso; Edward S. BoydenORCID; Eric BetzigORCID

<jats:title>Combining expansion and the lattice light sheet</jats:title> <jats:p> Optical and electron microscopy have made tremendous inroads into understanding the complexity of the brain. Gao <jats:italic>et al.</jats:italic> introduce an approach for high-resolution tracing of neurons, their subassemblies, and their molecular constituents over large volumes. They applied their method, which combines expansion microscopy and lattice light-sheet microscopy, to the mouse cortical column and the entire <jats:italic>Drosophila</jats:italic> brain. The approach can be performed at speeds that should enable high-throughput comparative studies of neural development, circuit stereotypy, and structural correlations to neural activity or behavior. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" related-article-type="in-this-issue" xlink:href="10.1126/science.aau8302">eaau8302</jats:related-article> </jats:p>

Palabras clave: Multidisciplinary.

Pp. No disponible

CRISPR-mediated activation of a promoter or enhancer rescues obesity caused by haploinsufficiency

Navneet MatharuORCID; Sawitree RattanasophaORCID; Serena TamuraORCID; Lenka MaliskovaORCID; Yi Wang; Adelaide BernardORCID; Aaron HardinORCID; Walter L. Eckalbar; Christian VaisseORCID; Nadav AhituvORCID

<jats:title>CRISPRa corrects haploinsufficient obesity</jats:title> <jats:p> Loss-of-function mutation in one gene copy, termed haploinsufficiency, can lead to insufficient protein levels and result in human disease. Matharu <jats:italic>et al.</jats:italic> tested whether a CRISPR-based activation system (CRISPRa) could rescue a haploinsufficient phenotype by increasing the gene expression levels of the existing normal copy (see the Perspective by Montefiori and Nobrega). By delivering this system into the mouse hypothalamus using adeno-associated virus, they rescued the obesity phenotype caused by haploinsufficiency of either of two genes known to promote obesity when mutated in mice and humans. These results highlight the translational potential of the CRISPR activation system to treat haploinsufficient disease. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" related-article-type="in-this-issue" xlink:href="10.1126/science.aau0629">eaau0629</jats:related-article> ; see also p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6424" page="231" related-article-type="in-this-issue" vol="363" xlink:href="10.1126/science.aaw0635">231</jats:related-article> </jats:p>

Palabras clave: Multidisciplinary.

Pp. No disponible

Cerebellar modulation of the reward circuitry and social behavior

Ilaria CartaORCID; Christopher H. ChenORCID; Amanda L. SchottORCID; Schnaude DorizanORCID; Kamran KhodakhahORCID

<jats:title>The cerebellum and reward-driven behavior</jats:title> <jats:p> Damage to the cerebellum manifests itself in various forms of cognitive impairment and abnormal social behavior. However, the exact role the cerebellum plays in these conditions is far from clear. Working in mice, Carta <jats:italic>et al.</jats:italic> found direct projections from the deep cerebellar nuclei to the brain's reward center, a region called the ventral tegmental area (see the Perspective by D'Angelo). These direct projections allowed the cerebellum to play a role in showing a social preference. Intriguingly, this pathway was not prosocial on its own. Cerebellar inputs into the ventral tegmental area were more active during social exploration. Depolarization of ventral tegmental area neurons thus represents a similar reward stimulus as social interaction for mice. </jats:p> <jats:p> <jats:italic>Science</jats:italic> , this issue p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" related-article-type="in-this-issue" xlink:href="10.1126/science.aav0581">eaav0581</jats:related-article> ; see also p. <jats:related-article xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="doi" issue="6424" page="229" related-article-type="in-this-issue" vol="363" xlink:href="10.1126/science.aaw2571">229</jats:related-article> </jats:p>

Palabras clave: Multidisciplinary.

Pp. No disponible

Why we need fetal tissue research

Sally Temple; Lawrence S. B. Goldstein

<jats:p>A vocal minority in the United States is intent on stopping federal funding for research using human fetal tissue, citing stem cell–based or other alternatives as adequate. This view is scientifically inaccurate. It ignores the current limitations of stem cell research and disregards the value of fetal tissue research in finding therapies for incurable diseases. If there is to be continued rapid progress in treating cancer, birth defects, heart disease, and infectious diseases, then we need fetal tissue research.</jats:p>

Palabras clave: Multidisciplinary.

Pp. 207-207

News at a glance

<jats:p>A roundup of weekly science policy and related news.</jats:p>

Palabras clave: Multidisciplinary.

Pp. 208-210

Shake-up threatens novel U.S. ecology facility

Jeffrey Mervis

<jats:p>NEON science head quits, advisers fired after Battelle replaces two top managers.</jats:p>

Palabras clave: Multidisciplinary.

Pp. 211-212

Did neurons arise from an early secretory cell?

Elizabeth Pennisi

<jats:p>Cell lineage studies of comb jellies and other creatures may suggest a single ancient origin of the nervous system.</jats:p>

Palabras clave: Multidisciplinary.

Pp. 212-213

In Congo, fighting a virus and a groundswell of fake news

Laura Spinney

<jats:p>Armed conflict and political tensions stoke rumors and misinformation about Ebola.</jats:p>

Palabras clave: Multidisciplinary.

Pp. 213-214